Decoy Therapeutics secures $3.5M PIPE financing; shares surge
Seeking Alpha ·
Decoy Therapeutics ( DCOY ) entered into a $3.5M PIPE financing with a single healthcare-focused institutional investor. The company will use the net proceeds to advance its lead antiviral candidate into clinical trials. The PIPE is priced at $5.91/share, with closing expected on or
DYAX Investor Sentiment
Bullish (Long) 31% · Bearish (Short) 69%
359 participants
Related News
- Supreme Court rejects Trump's bid to fire Lisa Cook as her suit proceeds
- Comcast's breakup was 'long overdue,' analyst says as shares surge
- Las Vegas casino gaming win soars in May against a soft comparable
- ByteDance targets CPU mass production in H2 2027 to power AI push - SCMP
- IsoEnergy halts exploration at Saskatchewan project due to wildfire risk
- With Over $250B Raised This Year, The IPO Market Is Entering A New Era — A Look At What JPMorgan, Morgan Stanley Bankers Expect